Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ELLAONE 30 MG COMPRIMIDO RECUBIERTO CON PELICULA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ELLAONE 30 MG COMPRIMIDO RECUBIERTO CON PELICULA

Approved

STANDARD

ELLAONE 30 MG COMPRIMIDO RECUBIERTO CON PELICULA

Laboratoire Hra Pharma🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jul 30, 2024
Approval ID: 30d35942e0d8b6d9
Company: Laboratoire Hra Pharma
Type: Standard

Approval Details

Approval Id: 30d35942e0d8b6d9
Drug Cima Aemps Name: ELLAONE 30 MG COMPRIMIDO RECUBIERTO CON PELICULA
Register Number: 109522003IP3
Holder Company Name: Laboratoire Hra Pharma
Marketing Company Name: Ecofar Productos S.L.
Holder Company Detail Path: /organization/laboratoire-hra-pharma
Authorization Date: 2024-07-30
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 30 mg
Route Of Administration: VÍA ORAL
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Laboratoire Hra Pharma
Company Detail Path: /organization/laboratoire-hra-pharma

Company Information

Pharmaceutical Company Name: LABORATOIRE HRA PHARMA
Country Name: Spain
City Name: madrid,madrid,country_es
Address: CALLE EBRO 3

Active Ingredients

ULIPRISTAL ACETATO

30 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 30, 2024

Approval ID

30d35942e0d8b6d9

Type

Standard

Back to CIMA-AEMPS Approvals